← Companies|MagForce
Ma

MagForce

Berlin DEFounded 200250 employees
Private CapbiotechAcquiredOncology
Platform: NanoTherm GBM
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
MAG-6737MAG-6737Preclinical1ASOB7-H3TNFiNASHCF
MAG-3823MAG-3823Phase 12ERTWEE1KRASG12CiMSRA
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (2)
2028-02-04
MAG-3823 Interim
TTR Amyloidosis
Interim
2028-04-04
MAG-3823 Interim
RA
Interim